Amneal Pharmaceuticals, Inc. AMRX Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by Amneal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.
The official record: Amneal Pharmaceuticals, Inc.’s 10-K, filed February 27, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s operating lease liabilities (current)?
- Amneal Pharmaceuticals, Inc. (AMRX) reported operating lease liabilities (current) of $58.8M in Q4 2025.
- How has Amneal Pharmaceuticals, Inc.'s operating lease liabilities (current) changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s operating lease liabilities (current) increased by 25.0% year-over-year, from $47.04M to $58.8M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s operating lease liabilities (current)?
- Over 5 years (2020 to 2025), Amneal Pharmaceuticals, Inc.'s operating lease liabilities (current) has grown at a -1.2% compound annual growth rate (CAGR), from $62.53M to $58.8M.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.